Posttransplant recurrence of proteinuria in a case of focal segmental glomerulosclerosis associated with WT1 mutation

被引:15
作者
Ghiggeri, G. M. [1 ]
Aucella, F.
Caridi, G.
Bisceglia, L.
Ghio, L.
Gigante, M.
Perfumo, F.
Carraro, M.
Gesualdo, L.
机构
[1] G Gaslini Childrens Hosp, Lab Pathophysiol Uremia, Genoa, Italy
[2] G Gaslini Childrens Hosp, Dept Nephrol, Genoa, Italy
[3] IRCCS, Nephrol Unit, San Giovanni Rotondo, Italy
[4] IRCCS, Med Genet Serv, San Giovanni Rotondo, Italy
[5] ICP Pediat Nephrol, Dialysis & Transplantat Unit, Milan, Italy
[6] Univ Foggia, Nephrol Sect, Dept Biomed Sci, Foggia, Italy
[7] Univ Trieste, Inst Internal Med, Trieste, Italy
关键词
Frasier syndrome; FSGS; rephrotic syndrome; posttransplant recurrence; WT1; mutations;
D O I
10.1111/j.1600-6143.2006.01418.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Posttransplant recurrence of inherited focal segmental glomerulosclerosis (FSGS) is still an enigma owing to the evident paradox of the molecular origin of proteinuria. A young girl with FSGS for WT1 mutation (IVS9 + 4C > T) and Frasier syndrome received a renal transplant at the age of 11 years. After an initial good outcome with recovery of renal function, proteinuria re-appeared after 7 days and steadily increased up to a nephrotic range. Determination of plasma permeability activity showed concomitant high Palb (0.7). At this point, plasmapheresis was started and after nine cycles with 1500 mL exchange and albumin re-infusion, proteinuria decreased to normal range and is still normal after 3 years. This is the first description of posttransplant recurrence of proteinuria in Frasier syndrome that should be included in potential outcome of renal transplant in this category of patients. This observation confirms the concept that recurrence of proteinuria may occur in inherited forms of FSGS so far reported only for patients carrying NPHS2 mutations and reinforces the idea on multifactorial origin of the disease.
引用
收藏
页码:2208 / 2211
页数:4
相关论文
共 22 条
[1]   RECURRENT FOCAL GLOMERULOSCLEROSIS - NATURAL-HISTORY AND RESPONSE TO THERAPY [J].
ARTERO, M ;
BIAVA, C ;
AMEND, W ;
TOMLANOVICH, S ;
VINCENTI, F .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (04) :375-383
[2]   PLASMAPHERESIS REDUCES PROTEINURIA AND SERUM CAPACITY TO INJURE GLOMERULI IN PATIENTS WITH RECURRENT FOCAL GLOMERULOSCLEROSIS [J].
ARTERO, ML ;
SHARMA, R ;
SAVIN, VJ ;
VINCENTI, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (04) :574-581
[3]  
Baird Paul N., 1992, Human Molecular Genetics, V1, P301, DOI 10.1093/hmg/1.5.301
[4]   Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin [J].
Bertelli, R ;
Ginevri, F ;
Caridi, G ;
Dagnino, M ;
Sandrini, S ;
Di Duca, M ;
Emma, F ;
Sanna-Cherchi, S ;
Scolari, F ;
Neri, TM ;
Murer, L ;
Massella, L ;
Basile, G ;
Rizzoni, G ;
Perfumo, F ;
Ghiggeri, GM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (06) :1314-1321
[5]   Changing patterns in the histopathology of idiopathic nephrotic syndrome in children [J].
Bonilla-Felix, M ;
Parra, C ;
Dajani, T ;
Ferris, M ;
Swinford, RD ;
Portman, RJ ;
Verani, R .
KIDNEY INTERNATIONAL, 1999, 55 (05) :1885-1890
[6]  
BROYER M, 1992, J AM SOC NEPHROL, V2, pS255
[7]  
Candiano G, 2001, J AM SOC NEPHROL, V12, P143, DOI 10.1681/ASN.V121143
[8]   NPHS2 (podocin) mutations in nephrotic syndrome. clinical spectrum and fine mechanisms [J].
Caridi, G ;
Perfumo, F ;
Ghiggeri, GM .
PEDIATRIC RESEARCH, 2005, 57 (05) :54R-61R
[9]   Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome [J].
Carraro, M ;
Caridi, G ;
Bruschi, M ;
Artero, M ;
Bertelli, R ;
Zennaro, C ;
Musante, L ;
Candiano, G ;
Perfumo, F ;
Ghiggeri, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1946-1952
[10]   Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes [J].
Coward, RJM ;
Foster, RR ;
Patton, D ;
Ni, L ;
Lennon, R ;
Bates, DO ;
Harper, SJ ;
Mathieson, PW ;
Saleem, MA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03) :629-637